Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth

Glioblastoma is the most common and lethal brain tumor associated with only 12% median survival rate of patients. Despite the development of advanced surgical, radiation or use of combinations of anti-cancer drugs, treatment for glioblastoma patients is still a challenge. The major contributing fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjan, Alok, Wright, Stephen, Srivastava, Sanjay K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564593/
https://www.ncbi.nlm.nih.gov/pubmed/28512255
http://dx.doi.org/10.18632/oncotarget.17425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564593/
https://www.ncbi.nlm.nih.gov/pubmed/28512255
http://dx.doi.org/10.18632/oncotarget.17425

Ejemplares similares